Akseli Hemminki Selected Research

Akseli Hemminki Research Topics

Disease

149	Neoplasms (Cancer) 01/2023 - 01/2002
18	Melanoma (Melanoma, Malignant) 01/2023 - 07/2013
16	Infections 01/2020 - 03/2002
15	Prostatic Neoplasms (Prostate Cancer) 04/2024 - 02/2007
12	Ovarian Neoplasms (Ovarian Cancer) 08/2022 - 04/2002
11	Breast Neoplasms (Breast Cancer) 01/2017 - 02/2006
5	Neoplasm Metastasis (Metastasis) 01/2022 - 08/2010
4	Kidney Neoplasms (Kidney Cancer) 11/2022 - 10/2007
3	Head and Neck Neoplasms (Head and Neck Cancer) 01/2022 - 05/2010
3	Adenoviridae Infections (Adenovirus Infections) 01/2020 - 01/2005
3	Sarcoma (Soft Tissue Sarcoma) 01/2017 - 08/2014
3	Carcinoma (Carcinomatosis) 06/2009 - 04/2002
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 08/2008 - 08/2004
3	Ascites 04/2003 - 04/2002
2	Necrosis 01/2023 - 01/2020
2	Vaccinia 01/2023 - 05/2011
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2023 - 12/2020
2	Lung Neoplasms (Lung Cancer) 01/2023 - 05/2012
2	Experimental Melanoma 01/2022 - 01/2017
2	Malignant Mesothelioma 11/2021 - 11/2014
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2018 - 07/2012
2	Glioma (Gliomas) 02/2013 - 02/2004
2	Hyponatremia 02/2011 - 06/2010
2	Colorectal Neoplasms (Colorectal Cancer) 08/2010 - 09/2005
1	Hematologic Neoplasms (Hematological Malignancy) 03/2023
1	Uveal melanoma 03/2023
1	Newcastle Disease 01/2023
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023
1	Vulvar Neoplasms (Vulvar Cancer) 04/2022

Drug/Important Bio-Agent (IBA)

22	CytokinesIBA 01/2023 - 09/2010
19	Interleukin-2 (IL2)IBA 01/2023 - 01/2015
12	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2022 - 06/2010
12	Coxsackie and Adenovirus Receptor-Like Membrane ProteinIBA 04/2012 - 03/2002
10	Neutralizing AntibodiesIBA 01/2023 - 08/2002
10	Proteins (Proteins, Gene)FDA Link 10/2012 - 07/2005
7	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 09/2010
7	CD40 Ligand (CD40L)IBA 01/2021 - 04/2012
6	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2021
6	EpitopesIBA 01/2021 - 06/2010
6	AntigensIBA 06/2020 - 01/2012
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2015 - 02/2006
5	ChemokinesIBA 01/2023 - 11/2004
5	Antiviral Agents (Antivirals)IBA 01/2015 - 10/2011
5	IntegrinsIBA 04/2012 - 03/2002
5	adenovirus receptorIBA 10/2006 - 01/2002
4	Prostate-Specific Antigen (Semenogelase)IBA 04/2024 - 02/2013
4	Monoclonal AntibodiesIBA 01/2022 - 01/2010
4	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 01/2014
4	HMGB1 Protein (HMG1)IBA 06/2018 - 05/2012
4	Messenger RNA (mRNA)IBA 02/2016 - 03/2002
4	Trastuzumab (Herceptin)FDA Link 01/2016 - 02/2006
4	Thymidine KinaseIBA 01/2015 - 02/2004
4	Docetaxel (Taxotere)FDA Link 02/2013 - 02/2006
4	LuciferasesIBA 05/2012 - 11/2004
4	Hormones (Hormone)IBA 03/2012 - 02/2007
4	Fluorouracil (Carac)FDA LinkGeneric 05/2010 - 09/2005
3	VaccinesIBA 01/2021 - 04/2012
3	Pattern Recognition ReceptorsIBA 01/2020 - 11/2010
3	OvalbuminIBA 01/2018 - 01/2015
3	Biomarkers (Surrogate Marker)IBA 02/2016 - 03/2015
3	Green Fluorescent ProteinsIBA 05/2012 - 10/2006
3	Viral DNAIBA 02/2011 - 12/2004
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2010 - 03/2002
3	Epirubicin (Ellence)FDA LinkGeneric 12/2009 - 02/2006
3	Secretory Leukocyte Peptidase InhibitorIBA 02/2005 - 04/2003
2	Indicators and Reagents (Reagents)IBA 01/2023 - 06/2013
2	Dihydrotachysterol (AT 10)IBA 11/2022 - 04/2022
2	LigandsIBA 01/2022 - 10/2009
2	Thorium Dioxide (Thorotrast)IBA 01/2022 - 01/2022
2	AsbestosIBA 11/2021 - 11/2014
2	AntibodiesIBA 01/2021 - 10/2015
2	Interferon-gamma (Interferon, gamma)IBA 01/2020 - 01/2020
2	Complement System Proteins (Complement)IBA 01/2020 - 01/2010
2	Interleukin-6 (Interleukin 6)IBA 01/2019 - 09/2010
2	Interleukin-8 (Interleukin 8)IBA 06/2018 - 01/2018
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 10/2017 - 01/2016
2	AndrogensIBA 12/2016 - 12/2007
2	ErbB Receptors (EGF Receptor)IBA 03/2015 - 09/2010
2	Cancer VaccinesIBA 11/2014 - 01/2012
2	Adenosine Triphosphate (ATP)IBA 06/2013 - 05/2012
2	CalreticulinIBA 06/2013 - 05/2012
2	Blood Coagulation Factors (Coagulation Factor)IBA 01/2013 - 11/2009
2	Gemcitabine FDA Link 07/2012 - 01/2008
2	arginyl-glycyl-aspartic acidIBA 08/2010 - 10/2009
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2010 - 11/2004
2	Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA 10/2009 - 12/2006
2	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 02/2004 - 05/2002
1	SmokeIBA 01/2023
1	MucinsIBA 01/2022

Therapy/Procedure

82	Therapeutics 01/2023 - 01/2002
30	Immunotherapy 03/2023 - 05/2003
15	Drug Therapy (Chemotherapy) 01/2023 - 01/2008
7	Radiotherapy 11/2019 - 09/2009
6	Injections 01/2022 - 12/2013
6	Oncolytic Virotherapy 01/2021 - 08/2003
5	Cell- and Tissue-Based Therapy (Cell Therapy) 10/2017 - 01/2016
4	Aftercare (After-Treatment) 01/2021 - 07/2013
2	Immunomodulation 01/2017 - 11/2016
2	Castration 12/2016 - 02/2013
2	Adjuvant Chemotherapy 12/2009 - 09/2005